<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02449694</url>
  </required_header>
  <id_info>
    <org_study_id>OCS-LVR-022015</org_study_id>
    <nct_id>NCT02449694</nct_id>
  </id_info>
  <brief_title>Trial of the TransMedics Organ Care System™ Liver For Preserving and Assessing Donor Livers for Transplantation</brief_title>
  <acronym>REVIVE</acronym>
  <official_title>Single-arm Prospective Trial to Evaluate The Safety and Performance of The Portable Organ Care System (OCS™) Liver For Preserving and Assessing Donor Livers for Transplantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>TransMedics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>TransMedics</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, single-center controlled trial to evaluate the safety and performance of the
      portable Organ Care System (OCS) Liver for preservation and assessment of donor livers for
      transplantation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>May 2016</start_date>
  <completion_date type="Actual">January 2018</completion_date>
  <primary_completion_date type="Actual">September 19, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of donor livers preserved by OCS in a near physiologic state.</measure>
    <time_frame>Within 1 day of organ retrieval</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of events directly related to the use of the OCS Liver that led to the donor liver being deemed not clinically acceptable and, as a result, not transplanted</measure>
    <time_frame>Within 1 day of organ retrieval</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of donor livers maintained in a metabolically active and functioning state during preservation.</measure>
    <time_frame>Within 1 day of organ retrieval</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of donor livers monitored for perfusate temperatures, SvO2, hematocrit, Hepatic Artery flow rates, Portal Vein flow rate, Hepatic Artery pressure, Portal vein pressure, and bile production during preservation.</measure>
    <time_frame>Within 1 day of organ retrieval</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Frequency of liver graft-related serious adverse events</measure>
    <time_frame>30 days after transplantation</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">25</enrollment>
  <condition>Liver Preservation</condition>
  <arm_group>
    <arm_group_label>OCS Liver</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>OCS Liver will be used to preserve the donor liver</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>OCS Liver</intervention_name>
    <description>OCS Liver will be used to preserve the donor liver</description>
    <arm_group_label>OCS Liver</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Registered male or female primary Liver transplant candidate

          -  Age ≥18 years old

          -  Signed: written informed consent

        Exclusion Criteria:

          -  Acute, fulminant liver failure;

          -  Prior solid organ or bone marrow transplant;

          -  Chronic use of hemodialysis or diagnosis of chronic renal failure, defined as chronic
             serum creatinine of &gt;3 mg/dl (&gt;265 mmol/L) for &gt;2 weeks and/or requiring hemodialysis;

          -  Multi-organ transplant;

          -  Ventilator dependent;

          -  Dependent on &gt; 1 IV inotrope to maintain hemodynamics;

          -  Malignancy excluding HCC;

          -  Infection.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>St. James's University Hospital</name>
      <address>
        <city>Leeds</city>
        <state>West Yorkshire</state>
        <zip>LS9 7 TF</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 11, 2015</study_first_submitted>
  <study_first_submitted_qc>May 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2015</study_first_posted>
  <last_update_submitted>April 4, 2018</last_update_submitted>
  <last_update_submitted_qc>April 4, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Liver Extracts</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

